NMR Reaction-Monitoring as a Process Analytical Technique - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

NMR Reaction-Monitoring as a Process Analytical Technique
The authors describe the benefits of nuclear magnetic resonance (NMR) compared with traditional monitoring techniques. They also discuss how NMR reaction monitoring provides a new process analytical technology tool for industry.


Pharmaceutical Technology
pp. s19-s21

References

1. M.A. Bernstein, Spectrosc. Eur. 19, 11–13 (2007).

2. S.K. Kuster, E. Danieli, B. Blumich, and F. Casanova, Phys. Chem. Chem. Phys. 13, 13172–13176 (2011).

3. M. Maiwald, H. H. Fischer, Y.K. Kim, K. Albert, and H. Hasse, Jrnl. Magn. Reson. 166 (2) 135–146 (2004).

4. M.A. Bernstein, M. Stefinovic, and C.J. Sleigh, Magn. Reson. Chem. 45 (7) 564–571 (2007).

5. J. Sudmeier, U.L. Gunther, K. Albert, and W. Bachovchin, Jrnl. Mag. Res. A, 118 (2) 145–156 (1996).

6. D.B. Green, J. Lane, and R.M. Wing, Appl. Spectrosc. 41 (5) 847–851 (1987).

7. M. Khajeh, M. A. Bernstein, and G. A. Morris, Magn. Reson. Chem. 48 (7) 516–522 (2010).

8. Mestrelab Research, http://mestrelab.com/.

9. M. Zell et al., presentation at SMASH—Small Molecule NMR Conference (Portland, 2010).

10. D.A. Foley et al., J. Org. Chem. (2011) in press.

11. A.C. Barrios Sosa et al., Org. Process Res. Dev. 15 (4) 444–454 (2011).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
9%
All of the above.
45%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here